CRVSCorvus Pharmaceuticals, Inc.
$10.51+37% 1Y
$10.51
$6.5052 weeks$25.52
Is the price fair?
What CRVS's price assumes
- Price / book
- 6.13
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 6.13
- Market capitalisation84.1 million shares, counted Aug 6, 2026
- $884M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks
Biotechnology
Ranks #193 of 194 by RyuScore